- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Identifying Key Risk Factors for Heart Failure
Robert Groves, MD, leads a panel discussion surrounding risk factors related to heart disease.
EP: 1.Identifying Key Risk Factors for Heart Failure
EP: 2.Socioeconomic Factors Impacting Development of Cardiac Disease
EP: 3.Distinguishing Between Heart Failure Classifications
EP: 4.Staging Heart Failure and the Importance of Early Diagnosis
EP: 5.The Role of the Primary Care Physician in Heart Failure Management
EP: 6.Four Pillars of Heart Failure Therapy
EP: 7.Selecting Optimal First-line Therapy for Patients Diagnosed with Heart Failure
EP: 8.Key Takeaways From Heart Failure Clinical Trials
EP: 9.Navigating the Patient Journey Through Heart Failure Diagnosis
EP: 10.Strategies for Treating Preserved Ejection Fraction (HFpEF)
EP: 11.Treatment Optimization Challenges Associated With Heart Failure
EP: 12.Financial Barriers Impeding Optimal Heart Failure Treatment
EP: 13.Trajectory of Heart Failure Treatment Strategies
EP: 14.Key Takeaways from Experts in Heart Failure Management
This is a video synopsis/summary of a panel discussion involving Robert Groves, MD, executive vice president and chief medical officer, Banner |Aetna; Eugene E. Wright Jr, MD, consulting associate, Department of Medicine, Duke University Medical Center, and medical director for performance improvement, South Piedmont Area Health Education Center; Nancy Albert, PhD, CCNS, CCRN, CHFN, NE-BC, FAHA, FCCM, FHFSA, FAAN, associate chief nursing officer, research and innovation, and clinical nurse specialist at the Kaufman Center for Heart Failure Treatment and Recovery at the Cleveland Clinic; Nihar Desai, MD, MPH, vice chief, cardiovascular medicine at the Yale School of Medicine; and Kelly Marie Axsom, MD, medical director, Centralized Heart Failure Management Program at New York Presbyterian Hospital, and assistant professor of medicine at Columbia University Medical Center. The panel discusses updates in heart failure management, analyzing unmet needs and future considerations. Desai provides an overview of heart failure epidemiology, noting the significant burden in the US with an estimated 7 to 8 million individuals affected. Prevalence is increasing due to aging population and rise in risk factors like hypertension, kidney disease, diabetes, and valvular heart disease. There are also disparities across sex, race, and ethnicity. Albert expands on risk factors, highlighting lifestyle choices like sedentary behaviors and comorbid conditions like obesity and genetics. The panel aims to highlight key guideline updates and the evolving disease landscape regarding heart failure.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
